47
In band
Moving averages
SMA 200$3.64-10.99%
Company profile
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that decodes biology by integrating technological innovations in biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company is headquartered in Salt Lake City, Utah.
SectorHealthcare
IndustryBiotechnology
Market cap$1.72B
P/E ratioNone
EPS$-1.01
Beta1.071
Dividend yield0.00%
52-week high$7.18
52-week low$2.77
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 48
VRTX
Vertex Pharmaceuticals Inc
RSI 46
CRSP
CRISPR Therapeutics AG
RSI 44
IOVA
Iovance Biotherapeutics Inc
RSI 69
MRNA
Moderna Inc
RSI 62
VKTX
Viking Therapeutics Inc
RSI 40
SRPT
Sarepta Therapeutics Inc
RSI 55
EDIT
Editas Medicine Inc
RSI 43
NVAX
Novavax Inc
RSI 57
DNA
Ginkgo Bioworks Holdings Inc - Class A
RSI 46
RSI alerts for RXRX
Get an email the moment Recursion Pharmaceuticals Inc crosses into oversold or overbought territory. Nothing else, ever.
Add alertData last updated 13 September 2026 at 4:26 AM EDT